Mohsen A. Hedaya
Basic Pharmacokinetics
Mohsen A. Hedaya
Basic Pharmacokinetics
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book introduces pharmacokinetic concepts to beginners to help them understand the absorption, distribution, metabolism and excretion of drugs. After a basic introduction to pharmacokinetics and its related fields, the book introduces readers to quantitative pharmacokinetic relations and the interplay between pharmacokinetic parameters.
Andere Kunden interessierten sich auch für
- V A JithanAdvances in Drug Delivery102,99 €
- B S SanmathiDispensing Pharmacy121,99 €
- Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to ApplicationsPharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications123,99 €
- Anas T. AlhamdanyOral Gastroretentive Floating In-Situ Gelling System of Furosemide25,99 €
- Zvetanka ZhivkovaApplication of QSPkR for prediction of key pharmacokinetic parameters25,99 €
- Rick NgDrugs113,99 €
- Stephen K. HallChemical Exposure and Toxic Responses220,99 €
-
-
-
This book introduces pharmacokinetic concepts to beginners to help them understand the absorption, distribution, metabolism and excretion of drugs. After a basic introduction to pharmacokinetics and its related fields, the book introduces readers to quantitative pharmacokinetic relations and the interplay between pharmacokinetic parameters.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Routledge
- 3. Auflage
- Seitenzahl: 464
- Erscheinungstermin: 13. September 2023
- Englisch
- Abmessung: 250mm x 175mm x 29mm
- Gewicht: 974g
- ISBN-13: 9780367752149
- ISBN-10: 036775214X
- Artikelnr.: 67824816
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Routledge
- 3. Auflage
- Seitenzahl: 464
- Erscheinungstermin: 13. September 2023
- Englisch
- Abmessung: 250mm x 175mm x 29mm
- Gewicht: 974g
- ISBN-13: 9780367752149
- ISBN-10: 036775214X
- Artikelnr.: 67824816
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Mohsen A. Hedaya, PharmD, PhD, is a professor at the Faculty of Pharmacy, Tanta University, Egypt, and is currently on leave to work at the Faculty of Pharmacy, Kuwait University, Kuwait. He received his Bachelor of Science in Pharmacy degree Tanta University, and his Doctor of Pharmacy and Doctor of Philosophy degrees from the University of Minnesota, USA. He joined the College of Pharmacy, Washington State University, USA, in 1993 as an Assistant Professor of Pharmaceutical Sciences. After returning to Egypt in 1999, he was promoted to the rank of associate and then full professor. He served as the Chair of the Clinical Pharmacy Department and Vice Dean for Academic Affairs at the Faculty of Pharmacy, Tanta University. Dr. Hedaya's area of interest is pharmacokinetics. He has taught basic and advanced pharmacokinetic classes to professional pharmacy students and graduate students in Egypt, the United States, and Kuwait. His research interest includes pharmacokinetic drug interactions, drug delivery to the brain, pharmacokinetic computer simulations, and bioequivalent study design and data analysis. The computer-based and online educational materials developed by Dr. Hedaya in the area of pharmacokinetics are currently being used by more than 350 educational, research, and industrial institutions around the world.
1.Introduction to Pharmacokinetics. 2.Drug Pharmacokinetics Following
Single Intravenous Bolus Administration: Drug Distribution. 3.Drug
Pharmacokinetics Following a Single IV Bolus Administration: Drug
Clearance. 4.Drug Pharmacokinetics Following Single IV Bolus
Administration: The Rate of Drug Elimination. 5.Drug Absorption Following
Extravascular Administration: Biological, Physicochemical, and Formulation
Considerations. 6.Drug Pharmacokinetics Following Single Oral Drug
Administration: The Rate of Drug Absorption. 7.Drug Pharmacokinetics
Following Single Oral Drug Administration: The Extent of Drug Absorption.
8.Bioequivalence. 9.Drug Pharmacokinetics during Constant Rate IV Infusion,
the Steady State concept. 10.Steady State during Multiple Drug
Administration. 11.Renal Drug Excretion. 12.Metabolite Pharmacokinetics.
13.Nonlinear Pharmacokinetics. 14.Multicompartment Pharmacokinetic Models.
15.Drug Pharmacokinetics Following Administration by Intermittent
Intravenous Infusions. 16.Physiological Approach to Hepatic Clearance.
17.Pharmacokinetics in Patients with Eliminating Organ Dysfunction.
18.Noncompartmental Approach in Pharmacokinetic Data Analysis.
19.Pharmacokinetic-Pharmacodynamic Modeling. 20.Pharmacogenetics: The
Genetic Basis of Pharmacokinetic and Pharmacodynamic Variability.
21.Therapeutic Drug Monitoring. 22.Pharmacometic Applications in Drug
Development and Individualization of Drug Therapy. 23.Answer to Practice
Problems.
Single Intravenous Bolus Administration: Drug Distribution. 3.Drug
Pharmacokinetics Following a Single IV Bolus Administration: Drug
Clearance. 4.Drug Pharmacokinetics Following Single IV Bolus
Administration: The Rate of Drug Elimination. 5.Drug Absorption Following
Extravascular Administration: Biological, Physicochemical, and Formulation
Considerations. 6.Drug Pharmacokinetics Following Single Oral Drug
Administration: The Rate of Drug Absorption. 7.Drug Pharmacokinetics
Following Single Oral Drug Administration: The Extent of Drug Absorption.
8.Bioequivalence. 9.Drug Pharmacokinetics during Constant Rate IV Infusion,
the Steady State concept. 10.Steady State during Multiple Drug
Administration. 11.Renal Drug Excretion. 12.Metabolite Pharmacokinetics.
13.Nonlinear Pharmacokinetics. 14.Multicompartment Pharmacokinetic Models.
15.Drug Pharmacokinetics Following Administration by Intermittent
Intravenous Infusions. 16.Physiological Approach to Hepatic Clearance.
17.Pharmacokinetics in Patients with Eliminating Organ Dysfunction.
18.Noncompartmental Approach in Pharmacokinetic Data Analysis.
19.Pharmacokinetic-Pharmacodynamic Modeling. 20.Pharmacogenetics: The
Genetic Basis of Pharmacokinetic and Pharmacodynamic Variability.
21.Therapeutic Drug Monitoring. 22.Pharmacometic Applications in Drug
Development and Individualization of Drug Therapy. 23.Answer to Practice
Problems.
1.Introduction to Pharmacokinetics. 2.Drug Pharmacokinetics Following Single Intravenous Bolus Administration: Drug Distribution. 3.Drug Pharmacokinetics Following a Single IV Bolus Administration: Drug Clearance. 4.Drug Pharmacokinetics Following Single IV Bolus Administration: The Rate of Drug Elimination. 5.Drug Absorption Following Extravascular Administration: Biological, Physicochemical, and Formulation Considerations. 6.Drug Pharmacokinetics Following Single Oral Drug Administration: The Rate of Drug Absorption. 7.Drug Pharmacokinetics Following Single Oral Drug Administration: The Extent of Drug Absorption. 8.Bioequivalence. 9.Drug Pharmacokinetics during Constant Rate IV Infusion, the Steady State concept. 10.Steady State during Multiple Drug Administration. 11.Renal Drug Excretion. 12.Metabolite Pharmacokinetics. 13.Nonlinear Pharmacokinetics. 14.Multicompartment Pharmacokinetic Models. 15.Drug Pharmacokinetics Following Administration by Intermittent Intravenous Infusions. 16.Physiological Approach to Hepatic Clearance. 17.Pharmacokinetics in Patients with Eliminating Organ Dysfunction. 18.Noncompartmental Approach in Pharmacokinetic Data Analysis. 19.Pharmacokinetic-Pharmacodynamic Modeling. 20.Pharmacogenetics: The Genetic Basis of Pharmacokinetic and Pharmacodynamic Variability. 21.Therapeutic Drug Monitoring. 22.Pharmacometic Applications in Drug Development and Individualization of Drug Therapy. 23.Answer to Practice Problems.
1.Introduction to Pharmacokinetics. 2.Drug Pharmacokinetics Following
Single Intravenous Bolus Administration: Drug Distribution. 3.Drug
Pharmacokinetics Following a Single IV Bolus Administration: Drug
Clearance. 4.Drug Pharmacokinetics Following Single IV Bolus
Administration: The Rate of Drug Elimination. 5.Drug Absorption Following
Extravascular Administration: Biological, Physicochemical, and Formulation
Considerations. 6.Drug Pharmacokinetics Following Single Oral Drug
Administration: The Rate of Drug Absorption. 7.Drug Pharmacokinetics
Following Single Oral Drug Administration: The Extent of Drug Absorption.
8.Bioequivalence. 9.Drug Pharmacokinetics during Constant Rate IV Infusion,
the Steady State concept. 10.Steady State during Multiple Drug
Administration. 11.Renal Drug Excretion. 12.Metabolite Pharmacokinetics.
13.Nonlinear Pharmacokinetics. 14.Multicompartment Pharmacokinetic Models.
15.Drug Pharmacokinetics Following Administration by Intermittent
Intravenous Infusions. 16.Physiological Approach to Hepatic Clearance.
17.Pharmacokinetics in Patients with Eliminating Organ Dysfunction.
18.Noncompartmental Approach in Pharmacokinetic Data Analysis.
19.Pharmacokinetic-Pharmacodynamic Modeling. 20.Pharmacogenetics: The
Genetic Basis of Pharmacokinetic and Pharmacodynamic Variability.
21.Therapeutic Drug Monitoring. 22.Pharmacometic Applications in Drug
Development and Individualization of Drug Therapy. 23.Answer to Practice
Problems.
Single Intravenous Bolus Administration: Drug Distribution. 3.Drug
Pharmacokinetics Following a Single IV Bolus Administration: Drug
Clearance. 4.Drug Pharmacokinetics Following Single IV Bolus
Administration: The Rate of Drug Elimination. 5.Drug Absorption Following
Extravascular Administration: Biological, Physicochemical, and Formulation
Considerations. 6.Drug Pharmacokinetics Following Single Oral Drug
Administration: The Rate of Drug Absorption. 7.Drug Pharmacokinetics
Following Single Oral Drug Administration: The Extent of Drug Absorption.
8.Bioequivalence. 9.Drug Pharmacokinetics during Constant Rate IV Infusion,
the Steady State concept. 10.Steady State during Multiple Drug
Administration. 11.Renal Drug Excretion. 12.Metabolite Pharmacokinetics.
13.Nonlinear Pharmacokinetics. 14.Multicompartment Pharmacokinetic Models.
15.Drug Pharmacokinetics Following Administration by Intermittent
Intravenous Infusions. 16.Physiological Approach to Hepatic Clearance.
17.Pharmacokinetics in Patients with Eliminating Organ Dysfunction.
18.Noncompartmental Approach in Pharmacokinetic Data Analysis.
19.Pharmacokinetic-Pharmacodynamic Modeling. 20.Pharmacogenetics: The
Genetic Basis of Pharmacokinetic and Pharmacodynamic Variability.
21.Therapeutic Drug Monitoring. 22.Pharmacometic Applications in Drug
Development and Individualization of Drug Therapy. 23.Answer to Practice
Problems.
1.Introduction to Pharmacokinetics. 2.Drug Pharmacokinetics Following Single Intravenous Bolus Administration: Drug Distribution. 3.Drug Pharmacokinetics Following a Single IV Bolus Administration: Drug Clearance. 4.Drug Pharmacokinetics Following Single IV Bolus Administration: The Rate of Drug Elimination. 5.Drug Absorption Following Extravascular Administration: Biological, Physicochemical, and Formulation Considerations. 6.Drug Pharmacokinetics Following Single Oral Drug Administration: The Rate of Drug Absorption. 7.Drug Pharmacokinetics Following Single Oral Drug Administration: The Extent of Drug Absorption. 8.Bioequivalence. 9.Drug Pharmacokinetics during Constant Rate IV Infusion, the Steady State concept. 10.Steady State during Multiple Drug Administration. 11.Renal Drug Excretion. 12.Metabolite Pharmacokinetics. 13.Nonlinear Pharmacokinetics. 14.Multicompartment Pharmacokinetic Models. 15.Drug Pharmacokinetics Following Administration by Intermittent Intravenous Infusions. 16.Physiological Approach to Hepatic Clearance. 17.Pharmacokinetics in Patients with Eliminating Organ Dysfunction. 18.Noncompartmental Approach in Pharmacokinetic Data Analysis. 19.Pharmacokinetic-Pharmacodynamic Modeling. 20.Pharmacogenetics: The Genetic Basis of Pharmacokinetic and Pharmacodynamic Variability. 21.Therapeutic Drug Monitoring. 22.Pharmacometic Applications in Drug Development and Individualization of Drug Therapy. 23.Answer to Practice Problems.